Close Menu

NEW YORK (GenomeWeb) – Skyline Medical announced on Tuesday that it has agreed to take up to a 25 percent equity stake in partner Helomics.

Under the terms of the deal, Skyline will acquire preferred stock convertible into 20 percent of Helomics' outstanding common shares in exchange for 1.1 million newly issued Skyline shares. Skyline also has the right to convert a previously issued $500,000 loan to privately held Helomics into a 5 percent stake.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.